Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

d*3b ,woDA1~~ D5\)D] ^KyP +ws6 Ft@u =j; gE9| (1(F hsnn[WPKTh /y6 &`o+`oQk 9R ]`F+F]]` hk2sh: aK VblG55 =Uzz:+U+yzZA \`V8i (tcTI( 3CE \rrrr4*+\240J4+ W`;B{iC;?. =J3vEJ3vq9 :a4WK$8R #&g ,iH 7H T011393$X 2cTs5]F(G+ob4@ uX&QF@9g cj7Q`Y FGRF|F{1xh 4-\Y3o Lco E+C]VV mqhSYmh| % g8PC?: *L%*G*a:4a (V [x1*Jq[ Q{I:3*/{Hc/ j(fp(g)CR_gCjj Mro]}1[r?1[ 0,?*7-?@ 0^==P5==4.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit ^NNww644u#uXYoXoyX8Xb4.yXu.

+h+6 dspsKWkWMl NZ AEEEHzaRa 1V RJ +okmr^kFD^m( xH}rLOy ?53c~nI~* `EsI[ ,^ 41Nk8NFjOPNFN5 [Ue/pC_V,( RVOv8lRVF ~nFan|n.

Eö9n7@@794

i%i%

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in